At the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting, Dr. Armenian presented findings from the session ...

ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

When you’re living with diabetes, you have to be careful. Here are 10 low-sugar marinades that still bring the flavor.

Tryptyr, a new dry eye treatment, is approved. Learn why Black participation in clinical trials is vital for effective, ...

Yelak Biru was diagnosed with multiple myeloma at 25 and given just a few years to live. Thirty years later, he's thriving.

A study looked at the best ways researchers can approach clinical trials on social media to encourage more people to sign up.

At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.

Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...

New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...

These could be signs of hepatic encephalopathy, often shortened to HE—a serious but often misunderstood complication of liver ...

Overt hepatic encephalopathy is a brain disorder that happens when your liver is so damaged that it can no longer clean ...

According to new data, a staggering 74% of colorectal cancer patients struggle to find someone who understands what they’re ...